☰

Laura L. Hagerty, Ph.D. - Publications

Affiliations: 
2007 Duke University, Durham, NC 
Area:
Pharmacology
Tree Info Grants Similar researchers PubMed Report error

4/7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Carlson DA, Franke AS, Weitzel DH, Speer BL, Hughes PF, Hagerty L, Fortner CN, Veal JM, Barta TE, Zieba BJ, Somlyo AV, Sutherland C, Deng JT, Walsh MP, MacDonald JA, et al. Fluorescence linked enzyme chemoproteomic strategy for discovery of a potent and selective DAPK1 and ZIPK inhibitor. Acs Chemical Biology. 8: 2715-23. PMID 24070067 DOI: 10.1021/Cb400407C  0.439
2012 Stimpson SA, Turner SM, Clifton LG, Poole JC, Mohammed HA, Shearer TW, Waitt GM, Hagerty LL, Remlinger KS, Hellerstein MK, Evans WJ. Total-body creatine pool size and skeletal muscle mass determination by creatine-(methyl-D3) dilution in rats. Journal of Applied Physiology (Bethesda, Md. : 1985). 112: 1940-8. PMID 22422801 DOI: 10.1152/Japplphysiol.00122.2012  0.393
2007 Hagerty L, Weitzel DH, Chambers J, Fortner CN, Brush MH, Loiselle D, Hosoya H, Haystead TA. ROCK1 phosphorylates and activates zipper-interacting protein kinase. The Journal of Biological Chemistry. 282: 4884-93. PMID 17158456 DOI: 10.1074/Jbc.M609990200  0.577
2006 Hagerty L, Haystead TA. Delineating signal transduction pathways in smooth muscle through focused proteomics. Expert Review of Proteomics. 3: 75-85. PMID 16445352 DOI: 10.1586/14789450.3.1.75  0.556
Low-probability matches (unlikely to be authored by this person)
2019 Baker M, Griggs R, Byrne B, Connolly AM, Finkel R, Grajkowska L, Haidet-Phillips A, Hagerty L, Ostrander R, Orlando L, Swoboda K, Watson M, Howell RR. Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps. Jama Neurology. PMID 31107518 DOI: 10.1001/Jamaneurol.2019.1206  0.124
2014 Faber C, Zhu ZJ, Castellino S, Wagner DS, Brown RH, Peterson RA, Gates L, Barton J, Bickett M, Hagerty L, Kimbrough C, Sola M, Bailey D, Jordan H, Elangbam CS. Cardiolipin profiles as a potential biomarker of mitochondrial health in diet-induced obese mice subjected to exercise, diet-restriction and ephedrine treatment. Journal of Applied Toxicology : Jat. 34: 1122-9. PMID 25132005 DOI: 10.1002/jat.3030  0.095
2020 Smith EC, Conklin LS, Hoffman EP, Clemens PR, Mah JK, Finkel RS, Guglieri M, Tulinius M, Nevo Y, Ryan MM, Webster R, Castro D, Kuntz NL, Kerchner L, Morgenroth LP, ... ... Hagerty L, et al. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study. Plos Medicine. 17: e1003222. PMID 32956407 DOI: 10.1371/Journal.Pmed.1003222  0.077
Hide low-probability matches.